checkAd

     109  0 Kommentare Viemed Healthcare Announces Date and Time for Conference Call

    LAFAYETTE, La., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Year End Conference Call on Thursday, March 7, 2024 at 11:00 a.m. ET.

    Interested parties may participate in the call by dialing:

    877-407-6176 (US Toll-Free)
    +1-201-689-8451 (International)

    Financial professionals are invited to call in to register in advance to ask questions. To pre-register as a qualified caller, please e-mail investorinfo@viemed.com by 12:00 p.m. ET Wednesday, March 6, 2024.

    Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=Axpi0DD ...

    Following the live call, a replay will be available in the Investor Relations section of the Company’s website, www.viemed.com.

    ABOUT VIEMED HEALTHCARE, INC.

    Viemed is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counseling to patients in their homes using cutting edge technology. Visit our website at www.viemed.com.

    For further information, please contact:

    Glen Akselrod
    Bristol Capital
    905-326-1888
    glen@bristolir.com

    Todd Zehnder
    Chief Operating Officer
    Viemed Healthcare, Inc.
    337-504-3802
    investorinfo@viemed.com





    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Viemed Healthcare Announces Date and Time for Conference Call LAFAYETTE, La., Feb. 20, 2024 (GLOBE NEWSWIRE) - Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its …

    Schreibe Deinen Kommentar

    Disclaimer